|
|
|
Insider
Information: |
Patel Snehal |
Relationship: |
CEO and CFO, Director,... |
City: |
Stafford |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
5,534,602 |
|
Indirect Shares
|
2,712,886 |
|
|
Direct
Value |
$79,255,501 |
|
|
Indirect Value
|
$38,848,528 |
|
|
Total
Shares |
8,247,488 |
|
|
Total
Value |
$118,104,028 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Greenwich Lifesciences, Inc. |
GLSI |
CEO and CFO, Director,... |
2024-08-06 |
5,534,602 |
2022-06-24 |
2,712,886 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
66 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2023-11-03 |
4 |
B |
$9.11 |
$31,885 |
D/D |
3,500 |
5,307,677 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2023-11-10 |
4 |
B |
$10.17 |
$50,838 |
D/D |
5,000 |
5,312,677 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-02-15 |
4 |
B |
$11.07 |
$140,589 |
D/D |
12,700 |
5,325,377 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-02-16 |
4 |
B |
$11.16 |
$120,528 |
D/D |
10,800 |
5,336,177 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-03-04 |
4 |
B |
$13.03 |
$53,423 |
D/D |
4,100 |
5,340,277 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-03-05 |
4 |
B |
$12.49 |
$380,945 |
D/D |
30,500 |
5,343,777 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-03-05 |
4/A |
B |
$12.49 |
$43,715 |
D/D |
3,500 |
5,343,777 |
3.23 |
- |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-03-20 |
4 |
B |
$17.68 |
$26,520 |
D/D |
1,500 |
5,345,277 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-03-22 |
4 |
B |
$19.98 |
$49,950 |
D/D |
2,500 |
5,347,777 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-04-01 |
4 |
B |
$19.08 |
$57,240 |
D/D |
3,000 |
5,350,777 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-06-13 |
4 |
B |
$14.30 |
$2,499,998 |
D/D |
174,825 |
5,525,602 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-07-23 |
4 |
B |
$15.89 |
$23,835 |
D/D |
1,500 |
5,527,102 |
3.15 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-08-05 |
4 |
B |
$13.18 |
$72,490 |
D/D |
5,500 |
5,532,602 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
|
2024-08-06 |
4 |
B |
$13.81 |
$27,620 |
D/D |
2,000 |
5,534,602 |
3.23 |
% |
|
GLSI |
Greenwich Lifesciences, I... |
CHIEF EXECUTIVE OFFICEROfficer |
|
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,232,284 |
|
- |
|
GLSI |
Greenwich Lifesciences, I... |
CHIEF EXECUTIVE OFFICEROfficer |
|
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
749,336 |
|
- |
|
66 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|